Dihydroergotamine methanesulfonate
- Level
- Commodity
- Parent
- 51142400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142425This classification denotes a nonnarcotic analgesic and dopamine agonist with the molecular formula C33H37N5O5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81AXN7R2QT, chemically known as ergotoman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'.alpha.)-, monomethanesulfonate (salt), but more generally known as dihydroergotamine methanesulfonate, which bears US NIH Compound Identifier 10531. European Medicines Agency schedules dihydroergotamine methanesulfonate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07139MIG. Most nations, for tariff purposes, schedule dihydroergotamine methanesulfonate under HS 29396900. SMILES: C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4CCCCC4)NC(=O)[C@@H]5C[C@@H]6C7CCCC8C7C(C[NH]8)C[C@H]6N(C5)C.CS(=O)(=O)O.
Same parent
Under 51142400 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.